Blog Viewer

Association Between Treatment Progression, Disease Refractoriness, and Burden of Illness Among Hospitalized Patients With Status Epilepticus

By Currents Editor posted 04-21-2021 10:43


JAMA Neurology (04/05/21) DOI: 10.1001/jamaneurol.2021.0520

Guterman, Elan L.; Betjemann, John P.; Aimetti, Alex; et al.

Highly refractory status epilepticus (SE) is associated with increased hospitalization costs and worse outcomes, according to new research. The cross-sectional study evaluated 43,988 hospitalizations related to SE from 2016 through 2018 in the United States. Patients were categorized by the administration of antiseizure drugs given while hospitalized: low refractoriness (treatment with none or one intravenous antiseizure drug), moderate refractoriness (more than one I.V. antiseizure drug), and high refractoriness (treatment with one or more I.V. antiseizure drug, more than one I.V. anesthetic, and intensive care unit admission). Of the 14,694 admissions, 33.4% were for low refractory SE, 23.1% were for moderate refractory SE, and 43.5% were for highly refractory SE. Overall in-hospital mortality was 11.2%, with rates ranging from 4.6% for low refractory SE to 18.9% for highly refractory SE. Similarly, patients with high refractory SE also had longer median hospital length of stays and higher hospital costs. The findings highlight the large burden that SE places on patients and the U.S. health system, and suggest that interventions that keep SE from advancing to a more refractory state may be able to improve outcomes and reduce associated costs.


Gabrielle Horstman, MD/PhD This month we would like to highlight one of the new programs launched this year by the Inclusion in Neurocritical Care (INCC)  Committee– The INCC Virtual Book Club! This program was created in response to multiple requests from members like you during the 2020 Annual meeting. ...
Richard Leston,  APP Supervisor, Department of Neurosurgery, Clinical Preceptor of APP Neurosurgery Clerkship With: Alexis Catania, PA & Krista O’Leary PA-S South Shore University Hospital was preparing to open its brand-new Neuro ICU in March of 2020, eager to become a major neuroscience center ...
Journal of the American Medical Association (05/25/21)  DOI: 10.1001/jama.2021.5561 Roquilly, Antoine; Moyer, Jean Denis; Huet, Olivier; et al.   For the COBI clinical trial, researchers compared outcomes in adults with traumatic ...